SoloScript RNA Polymerase is a novel enzyme designed to reduce immunogenic double-stranded RNA (dsRNA) by-products in mRNAs synthesized by in vitro transcription (IVT).  Importantly, SoloScript can directly substitute for wild-type (WT) T7 RNA polymerase in IVT, reducing dsRNA by up to 85% while retaining IVT yields, efficiency, and key mRNA quality attributes, making it an attractive enhancement to existing production-scale processes.  

E107-B055B-1.00 is 1.00 mg/mL (10x) concentration supplied with a separate dilution buffer to optimize enzyme concentrations in your experiments.